CVS · 10-Q · 2026Q2 · Full report

Revenue Performance and Mix

CVS HEALTH Corp · 2026-08-05 · Importance 54 · Surprise 40 · In source text

Health Services revenue increased 11.5% to $51.8 billion in the second quarter and 11.3% to $100.0 billion for the first six months, driven by pharmacy drug mix and brand inflation. Health Care Benefits revenue rose 3.5% to $37.5 billion in the quarter and 3.4% to $73.5 billion year to date, with Government premium revenue increasing 9.9% and 10.7%, respectively. Commercial premium revenue declined 19.7% to $6.6 billion in the quarter and 21.8% to $12.6 billion year to date, primarily reflecting the exit from the individual exchange business. Pharmacy & Consumer Wellness revenue increased 0.7% to $33.8 billion in the quarter and 0.5% to $65.8 billion year to date.

Key facts

• Total consolidated revenues for the three months ended June 30, 2026 were $106,096 million, an increase of $7,181 million or 7.3% versus prior year. source
• Total consolidated revenues for the six months ended June 30, 2026 were $206,522 million, an increase of $13,019 million or 6.7% versus prior year. source
• Health Services segment total revenues for the three months ended June 30, 2026 were $51,795 million, up $5,342 million or 11.5% versus prior year. source
• Health Care Benefits segment total revenues for the three months ended June 30, 2026 were $37,538 million, up $1,280 million or 3.5% versus prior year. source
• Health Care Benefits segment premium revenues for the three months ended June 30, 2026 were $35,119 million, up 2.7% versus prior year. source
• Health Care Benefits segment Government premium revenues for the three months ended June 30, 2026 were $28,494 million, up $2,564 million or 9.9% versus prior year. source
• Pharmacy & Consumer Wellness segment total revenues for the three months ended June 30, 2026 were $33,816 million, up $235 million or 0.7% versus prior year. source

Impact estimates